Evaluation of Platelet-Rich Plasma by means of PRGF®-Endoret® protocol in leukemia cats: PDGF-BB and TGF-ß1 valuation

dc.centroUniversidad Cardenal Herrera-CEU
dc.contributor.authorSopena Juncosa, Joaquín Jesús
dc.contributor.authorSatué Ambrojo, Katiuska
dc.contributor.authorTorres Torrillas, Marta
dc.contributor.authorCarrillo Poveda, José María
dc.contributor.authorChicharro Alcántara, Deborah
dc.contributor.authorCerón, José J.
dc.contributor.authorMiguel Pastor, Laura
dc.contributor.authorPeláez Gorrea, Pau
dc.contributor.authorRubio Zaragoza, Mónica
dc.contributor.otherUCH. Departamento de Medicina y Cirugía Animal
dc.contributor.otherUCH. Cátedra de Fundación García Cugat
dc.contributor.otherUCH. Grupo de Investigación en Medicina Biorregenerativa y Cirugía Aplicada (BIOMED-SURGERY)
dc.contributor.otherProducción Científica UCH 2023
dc.date.accessioned2024-02-01T09:21:05Z
dc.date.available2024-02-01T09:21:05Z
dc.date.issued2023-01-26
dc.description.abstractIntroduction: Feline leukemia virus (FeLV) is a chronic disease that leads to the weakening of a cat's immune system. Platelet-rich plasma (PRP) offers therapeutic effects for multiple diseases, the use of PRP and growth factors (GFs) determination could be an alternative treatment to improve the quality of life in these patients. The objectives of this study were to determine and compare the concentration of platelets (PLTs), red blood cells (RBCs) and white blood cells (WBCs) between samples of whole blood (WB), PRP and platelet-poor plasma (PPP) fractions, and to evaluate the concentration of platelet-derived growth factor BB (PDGF-BB) and transforming growth factor β1 (TGF-β1) in both fractions in FeLV cats using a PRGF®-Endoret® protocol previously standardized in this species. Methods: WB was collected from 11 asymptomatic FeLV-positive cats. PRP and PPP was obtained following PRGF®-Endoret® technology according to centrifugation at 265 g for 10 min. Cellular components, RBCs, WBCs, PLTs, and the PDGF-BB and TGF-β1 concentrations in PRP and PPP fractions were determined. Results: PLT in the PRP fraction was statistically higher than WB and PPP fraction, with no statistical differences between WB and PPP. PLT concentration increased 1.4 times in PRP fraction compared to WB. Mean platelet volume (MPV) did not differ significantly between the WB, PRP, and PPP fractions. Compared to WB, the absolute numbers of RBCs and WBCs were decreased by 99% and more than 95% in the PRP and PPP fractions, respectively. TGF-ß1 concentrations increased in PRP vs. PPP, with no changes in PDGF-BB. Discussion: Based on the degree of PLT enrichment and the absence of RBCs and WBCs, this blood product could be classified as a Pure Platelet-Rich Plasma (P-PRP). The presence of GFs in PRP and PPP samples suggests that the PRGF®-Endoret® methodology is suitable for obtaining PRP in FeLV cats, despite future studies are necessary to optimize the technique, standardize the results and assess clinical efficacy.es_ES
dc.identifier.citationMiguel-Pastor, L., Satué, K., Chicharro, D., Peláez, P., Torres-Torrillas, M., Carrillo, J.M., Cerón, J.J., Sopena, J.J. & Rubio, M. (2023). Evaluation of Platelet-Rich plasma by means of PRGF®-Endoret® protocol in leukemia cats: PDGF-BB and TGF-ß1 valuation. Frontiers in Veterinary Science, vol. 10, art. 1110055 (26 jan.). DOI: https://doi.org/10.3389/fvets.2023.1110055es_ES
dc.identifier.doihttps://doi.org/10.3389/fvets.2023.1110055
dc.identifier.issn2297-1769 (Electrónico)
dc.identifier.urihttp://hdl.handle.net/10637/15263
dc.language.isoenes_ES
dc.publisherFrontiers Mediaes_ES
dc.relationUCH. Financiación Universidad
dc.relationEste artículo de investigación ha sido financiado por la Cátedra de Fundación García Cugat, vinculada a la Unidad de Cirugía del Departamento de Medicina y Cirugía Animal (UCHCEU) y por la Universidad CEU Cardenal Herrera (INDI21/54 e INDI22/53).
dc.relation.ispartofFrontiers in Veterinary Science, vol. 10
dc.relation.projectIDINDI21/54
dc.relation.projectIDINDI22/53
dc.rightsopen access
dc.rights.cchttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subjectGatoses_ES
dc.subjectCatses_ES
dc.subjectLeucemiaes_ES
dc.subjectLeukemiaes_ES
dc.subjectPlasma sanguíneoes_ES
dc.subjectBlood plasmaes_ES
dc.subjectFactores de crecimientoes_ES
dc.subjectGrowth factorses_ES
dc.subjectEnfermedad animales_ES
dc.subjectAnimal diseaseses_ES
dc.titleEvaluation of Platelet-Rich Plasma by means of PRGF®-Endoret® protocol in leukemia cats: PDGF-BB and TGF-ß1 valuationes_ES
dc.typeArtículoes_ES
dspace.entity.typePublicationes
relation.isAuthorOfPublication3ce0c111-0184-41b3-9ac3-b76a2e991f57
relation.isAuthorOfPublication471d28c0-13a5-45a9-8b63-ac93d4a4ab6f
relation.isAuthorOfPublication648e6806-83e6-4442-bac9-22dbed330de6
relation.isAuthorOfPublication2ede1b05-f72b-4a8c-b00a-9e9860d1d8b8
relation.isAuthorOfPublication2456f949-6224-4548-bf2b-c33c67c57de3
relation.isAuthorOfPublication50a25142-4fc6-4d4f-9a9a-1659b4bf42ba
relation.isAuthorOfPublicationc0425122-3dea-4ce7-8e01-084dcdf4b859
relation.isAuthorOfPublication.latestForDiscovery3ce0c111-0184-41b3-9ac3-b76a2e991f57

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Evaluation_Miguel_FIVS_2023.pdf
Size:
1.1 MB
Format:
Adobe Portable Document Format